Pacific Biosciences of California Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 19 Posts
1 2
Pacific Biosciences Upgraded To Overweight From Neutral At Piper Jaffray
Article By: The Fly Tuesday, October 15, 2019 7:33 AM EDT
Piper Jaffray analyst William Quirk upgraded Pacific Biosciences of California to Overweight from Neutral with an unchanged price target of $8.
In this article: PACB Also: ILMN
Read
Merger Arbitrage Spread Performance - Feb. 24, 2019
Article By: Mal Spink Sunday, February 24, 2019 2:18 PM EDT
This is the analysis and performance review of the top 20 US based cash merger arbitrage spreads for the week 19th-22nd February. Included in this week's report are the winners, losers and overall performance of the portfolio.
In this article: NXTM, RHT NOW IBM, TRCO, NXST, PACB, MNA, SPY, HIFR
Read
Illumina To Acquire Pacific Biosciences For $8 Per Share
Article By: The Fly Thursday, November 1, 2018 5:15 PM EDT
The agreement has been approved by the board of directors of Illumina and Pacific Biosciences. The acquisition complements Illumina sequencing solutions with accurate long-read sequencing capabilities to answer a set of complex genomic questions.
In this article: ILMN, PACB
Read
Pacific Biosciences Of California, Inc. Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Monday, February 12, 2018 5:44 PM EDT
Pacific Biosciences of California, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
In this article: PACB
Read
Pacific Biosciences Looks Promising As It Targets Low Competition Plant Genome Segment
Article By: KKD Healthcare Analytics Thursday, June 29, 2017 9:51 AM EDT
Pacific Biosciences has taken several remedial steps to ensure that Sequel systems gain wider approval in the market. These steps included designing software and chemical updates for the systems.
In this article: PACB
Read
Illumina Misses Revenue Forecast Causing Collateral Damage To Biotechs
Article By: Rod Raynovich Tuesday, October 11, 2016 11:00 PM EDT
Illumina shares crashed 25% to $139, after a warning on third quarter sales. The global leader in DNA sequencing systems warned that revenues missed forecast and would be $607M, well short of earlier guidance of $625-$630M.
In this article: TMO, RHHBY, IBB, ILMN, PACB, QGEN, XBI, XLV, FMI
Read
The Google Of Genetic Testing Looks Like A Buy Right Now
Article By: Steve Alexander Saturday, April 23, 2016 12:15 PM EDT
You don't often get good opportunities to buy into dominant players in enormous future growth markets at reasonable prices, but I believe that is exactly what we are getting right now with Illumina.
In this article: ILMN, AFFX, PACB
Read
Top Stock Stories For Tuesday - February 2, 2016
Article By: The Fly Tuesday, February 2, 2016 11:12 PM EDT
Stocks began the session in negative territory and remained there throughout the entire session. The early weakness was attributed to oil prices, which were down early and never recovered during the day.
In this article: BP, DD, DOW, F, GM, KORS, MAT, RCL, XOM, RHHBY, IDTI, PACB, ADT, GOOGL
Read
Rayno Molecular Diagnostics And Tools Update: CPHD, HOLX, PACB
Article By: Rod Raynovich Wednesday, December 2, 2015 6:31 PM EDT
Lackluster revenue growth has tempered stock gains since Q3 earnings reports however the sector has always had good investment potential due to M&A and new products. Stocks are up from October lows.
In this article: CPHD, ILMN, ABAX, HOLX, PACB, QGEN
Read
Biotech Rally Underway Trying To Overcome Gloomy Data
Article By: Rod Raynovich Saturday, November 14, 2015 11:14 AM EDT
As of mid-morning trading the biotech and drug sector is one of the few winners yesterday. Energy has been the major drag on the market (crude down again yesterday) but materials are trying to bounce back yesterday with the XLB up over 1%.
In this article: ALR, VRX, ALNY, CRIS, ILMN, INCY, ISIS, SGEN, AMGN, CELG, CLVS, GILD, PACB, QGEN, VRTX, XLB, FCSC, NSTG, RXDX
Read
Rayno Tools And Molecular Diagnostics: Looking For Value
Article By: Rod Raynovich Thursday, November 5, 2015 7:30 PM EDT
Life Science stocks took a big hit over the past summer and many have not fully recovered. The important metric to watch is sales growth because many of the smaller cap companies are still lagging in earnings growth so the PE tells you very little.
In this article: ALR, CPHD, GHDX, ILMN, LMNX, QDEL, ABAX, HOLX, NEOG, PACB, QGEN, FMI
Read
Snap-Back Rally In Biotech-But Lagging Other Sectors
Article By: Rod Raynovich Monday, March 30, 2015 11:15 PM EDT
We are in Day Two of the biotech rally that was sparked last Friday with the rumor supported by a Deutsche Bank analyst that Biomarin (BMRN) was a takeover target.
In this article: BMRN, ABBV, PCYC, XBI, XLV, REGN, AMGN, ALKS, CLVS, CLDX, FCSC, FMI, GLYC, ABAX, PACB, XON
Read
Rayno Dx And Tools: 2015 Q1 Mid Quarter Update-FMI, CSII, HOLX, ALR
Article By: Rod Raynovich Thursday, February 19, 2015 4:41 PM EDT
Major ETFs (FBT,IBB,XBI) are up about 10% YTD and our top performers are up over 10%.
In this article: FMI, CSII, HOLX, ALR, FBT, IBB, XBI, CPHD, ILMN, ABAX, QGEN, TMO, EXAS, GHDX, NEOG, NSTG, PACB, QDEL, SQNM, VRML
Read
E Small Cap Best & Worst - February 5, 2015
Article By: E.B. Capital Markets Thursday, February 5, 2015 8:35 AM EDT
The average small cap score is 52.11, which is below the four week moving average score of 54.41. The average small cap stock is trading -27.89% below its 52 week high, -1.03% below its 200 dma, and has 7.27 days to cover held short.
In this article: ELLI, ANAC, BABY, CNMD, PACB, QLGC, PKD, REDF, RIGL, QLTI, SIFY
Read
JPMorgan Healthcare Conference Notes #4: Next Gen Sequencing
Article By: Rod Raynovich Monday, January 19, 2015 7:11 PM EDT
Seminar: Harnessing the Power of Next Gen Sequencing: The View from Industry 1/12/15
In this article: FMI, GHDX, ILMN, PACB, SQNM, TMO
Read
Rayno Small Cap Picks: FCSC, PACB
Article By: Rod Raynovich Wednesday, January 14, 2015 6:28 PM EDT
Life Science small cap movers
In this article: FCSC, PACB
Read
1 to 16 of 19 Posts
1 2